New cholesterol drug artisterol put to the test in global trial

NCT ID NCT07405814

Recruiting now Disease control Sponsor: Zentiva, k.s. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a new drug called Artisterol can lower LDL (bad) cholesterol in adults with mildly high levels. About 106 participants will take either Artisterol or a placebo daily for 3 months, with clinic visits every 6 weeks. The main goal is to see how much Artisterol reduces LDL cholesterol compared to a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERLIPOPROTEINEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperlipoproteinemia low density lipoprotein cholesterol, mild elevation of

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERLIPOPROTEINEMIA

Contacts and locations

Locations

Polish Mother's memorial Hospital Research Institute
RECRUITING

Lodz, 93338, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.